Phase III germline BRCA mutated (gBRCAm) metastatic pancreatic cancer

Phase III pancreatic cancer study for patients with gBRCAm metastatic disease not progressed on first-line platinum chemotherapy; Innovative Trials' Clinical Enrolment Managers significantly increased enrolment in this complex study.